The authors wish to correct Figure 1 in this paper [1] to be as follows:
Figure 1.
Reaction scheme of the chitosan oligosaccharides–porcine circovirus type 2 (COS-PCV2) conjugate synthesis.
The authors wish to correct the order of references 9 and 10 in References Part of [1] to be as follows:
- 9.
- Wang, Z.; Zheng, L.; Yang, S.; Niu, R.; Chu, E.; Lin, X. N-acetylchitooligosaccharide is a potent angiogenic inhibitor both in vivo and in vitro. Biochem. Biophys. Res. Commun. 2007, 357, 26–31.
- 10.
- Wu, H.; Aam, B.B.; Wang, W.; Norberg, A.L.; Sørlie, M.; Eijsink, V.G.; Du, Y. Inhibition of angiogenesis by chitooligosaccharides with specific degrees of acetylation and polymerization. Carbohydr. Polym. 2012, 89, 511–518.
Reference
- Zhang, G.; Cheng, G.; Jia, P.; Jiao, S.; Feng, C.; Hu, T.; Liu, H.; Du, Y. The Positive Correlation of the Enhanced Immune Response to PCV2 Subunit Vaccine by Conjugation of Chitosan Oligosaccharide with the Deacetylation Degree. Mar. Drugs 2017, 15, 236. [Google Scholar] [CrossRef]
© 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).